| Financial Year |
March 31 2023 |
| Monetary Funds |
173,802,189.18 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
94,674,440.74 |
| Accounts Receivable |
844,916,925.87 |
| Advances to Suppliers |
154,220,921.04 |
| Other Receivables |
412,057,900.04 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
428,369,244.16 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
19,676,798.60 |
| Total Current Assets |
2,154,827,098.97 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
6,702,993.25 |
| Fixed Assetes |
3,329,031,197.02 |
| Under-construction Projects |
65,817,047.79 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
175,953,991.72 |
| R&D expenses |
9,187,824.28 |
| Goodwill |
5,135,159.40 |
| Long-Term Deferred and Prepaid Expenses |
1,179,270.55 |
| Deferred Income Tax Assets |
394,283,549.91 |
| Other Non-Current Assets |
34,327,818.43 |
| Sub-Total of Non-Current Assets |
4,022,096,337.78 |
| Total Assets |
6,176,923,436.75 |
| Short-Term Loans |
2,186,981,806.20 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
424,590,749.72 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
21,854,499.64 |
| Taxes Payable |
148,355,406.69 |
| Interest Payable |
1,535,059,090.60 |
| Dividend Payable |
64,186,752.27 |
| Other payables |
3,068,162,232.16 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
756,436,212.50 |
| Other Current Liabilities |
97,732,674.01 |
| Sub-Total of Current Liabilities |
6,807,951,976.08 |
| Long-term Loans |
264,847,510.30 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,250,023,123.45 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,584,042,776.13 |
| Total Liabilities |
8,391,994,752.20 |
| Paid-In Capital(Or Share Stock) |
627,157,512.00 |
| Capital Surplus |
1,898,487,992.38 |
| Surplus Reserve |
91,277,286.45 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-4,748,725,657.77 |
| Minority Stockholder's Interest |
-83,268,448.52 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-2,131,802,866.93 |
| Owner's Equity（Stockholder's Equity） |
-2,215,071,315.45 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,176,923,436.75 |
